Month: April 2014

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies

IDIBELL, University Hospital of Bellvitge and the Polytechnic University of Catalonia (UPC) have signed a cooperation agreement in the field of education, research and innovation to share knowledge and needs that will allow the development of new health technologies. The agreement establishes a framework for relations between the three institutions for future collaboration in order …

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies Read More »

Jaume Reventós: “Together we can move forward”

On Wednesday April 2, the auditorium of the University Hospital of Bellvitge hosted the presentation of the new IDIBELL general manager, Jaume Reventós. The event was attended by members of the delegate Commission of the institution Jordi Alberch , Vice Chancellor of the University of Barcelona ; Alfredo Garcia Director of the University Hospital of …

Jaume Reventós: “Together we can move forward” Read More »

3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna

On February 27th and 28th the University of Vienna hosted the second workshop of the European project IT-Liver, funded by the Marie Curie ITN (Initial Training Network) program of the European Commission (FP7) and coordinated by the head of the Biological clues of the invasive and metastasic phenotype research group at IDIBELL, Isabel Fabregat. In …

3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna Read More »

Discovery of a mechanism that makes tumor cells sugar addicted

For almost a hundred years ago is known that cancer cells feel a special appetite for a type of sugar called glucose. The tumor uses this molecule is like the gasoline which depends a sports car to burn faster and grows and multiplies rapidly. It is a little cash process from the energy point of …

Discovery of a mechanism that makes tumor cells sugar addicted Read More »

Described a molecular alteration associated with tuberous sclerosis and mTOR

Tuberous sclerosis (TSC, tuberous Sclerosis complex) is an uncommon genetic disease that causes benign tumors (called hamartomas) in the brain and other vital organs. In most cases there is involvement of the central nervous system with the appearance of cortical tuber, leading to various mental illnesses. Coordinated by the breast cancer research group leader, Miquel …

Described a molecular alteration associated with tuberous sclerosis and mTOR Read More »

Scroll to Top